Zevra Therapeutics Financial Overview
Zevra Therapeutics's market cap is currently $487.54M. The company's EPS TTM is $-0.01; its P/E ratio is 13.73; Zevra Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
